活化部分凝血酶原时间,APTT
1)APTT活化部分凝血酶原时间
1.Objective To explore the significance of blood platelets and prothrombin time(PT),active partial thromboplastin time(APTT) and fibrinogen content (FiB) in postoperative patients with breast carcinoma.05);活化部分凝血酶原时间(APTT)术后明显低于术前(P<0。
2.Methods:Make use of the PT、APTT、TT、FBG Sysmex CA-50 to unite the examination cirrhosis to get contain the deal with the normal person.方法利用SysmexCA-50血凝仪联合检测肝硬化患者与正常人的凝血酶原时间(PT)、活化部分凝血酶原时间(APTT)、凝血酶时间(TT)、纤维蛋白原(FBG)含量。
3.Objective: To explore the significance of blood platelet and prothrombin time (PT), active partial thromboplastin time(APTT) and fibrinogen content( FiB) in postoperative patients with breast carcinoma.05),活化部分凝血酶原时间(APTT)术后明显低于术前(p<0。
英文短句/例句

1.Study of relationship among heparin dosage,concentration and APTT in pulmonary thromboembolism肝素治疗肺血栓栓塞症抗凝剂量浓度与活化部分凝血酶原时间关系初步探讨
2.Determination standard of abnormal result for activated partial thromboplastin time活化的部分凝血活酶时间异常结果的判定标准
3.The Influence of Different Thromboplastins Upon the International Normalised ratio (INR) and the Prothrombin Time Ratio (PTR)组织凝血活酶对凝血酶原时间比率与国际正常化比率的影响
4.The Study of D-dimer、APTT and Fibrinogen in Ulcerative Colitis;D二聚体、部分凝血活酶时间及纤维蛋白原与溃疡性结肠炎相关性的研究
5.Use of EDTA Samples for Prothrombin time Measurement使用EDTA抗凝血检测凝血酶原时间
6.Clinical Practice of Detection of Serum Cholinesterase Activity,Prothrombin-time and Albumin in Patients with Liver Cirrhosis肝硬化患者血清胆碱酯酶活性、凝血酶原时间和白蛋白检测的临床应用
7.Influence of Aprotinin to Activated Clotting Time and Whole Blood Prothrombin Time during Cardiopulmonary Bypass;体外循环下抑肽酶对激活的全血凝固时间和全血凝血酶原时间的影响
8.Comparison of activated partial thromboplastion time reagent between made by oneself and imported reagent自制与进口活化部分凝血活酶试剂的比较
9.Standardization of Modes of Prothrombin Time Reporting in Patients with Liver Disease Associated with Viral Hepatitis;病毒性肝病患者凝血酶原时间标准化的研究
10.Clinical Research on Activation of Platelet and Prothrombin after Transcatheter Closure of Atrial Septal Defects;房间隔缺损封堵术后血小板活化和凝血酶原激活临床研究
11.Relationship of Child-Pugh class with plasma prothrombin time and serum liver fibrosis indexes in patients with cirrhosis肝硬化患者血浆凝血酶原时间和血清肝纤维化指标与Child-Pugh分级的关系
12.A primary study on the changes of blood coagulation factors in semen and liquefaction time of semen under Eviprostat treatment爱活尿通对精液中部分凝血因子及液化时间影响的初步研究
13.Serum Biochemical and Prothrombin Reference Rangers of SPF Closed Colony SD RatSPF级封闭群SD大鼠血清生化值及凝血酶原时间值的测定
14.Prokaryotic Expression,Purification and Procoagulant Activity Analysis of Recombinant Fibrinogen-related Domain Protein of Human fgl2 Prothrombinase人fgl2凝血酶原酶FRED结构域的原核表达、纯化及其凝血活性的鉴定
15.ConclusionThe APTT reagent made by oneself can replace the imp orted one.结论 自制APTT试剂可以代替进口活化部分凝血活酶试剂
16.A plasma protein that is converted into thrombin during blood clotting.凝血原酶一种血浆蛋白质,在血液凝聚时转化成凝血酵素
17.Study on the Relationship of Mutation of Prothrombin G20210A,Activated Protein C Resistance and Antithrombin in Patients with Coronary Heart Disease;凝血酶原G20210A突变、抗活化蛋白C和抗凝血酶与冠心病关系的研究
18.Dose-effect relationship of traditional Chinese medicine formula for promoting blood circulation to remove stasis on ADP-induced platelet aggregation and rabbit plasma thrombin time活血化瘀方对ADP诱导的家兔血小板聚集和凝血酶时间的影响及量效关系研究
相关短句/例句

Activated partial thromboplastin time活化部分凝血酶原时间
1.Methods: Plasma prothrombin time(PT), activated partial thromboplastin time(APTT),fibrinogen(Fg), thrombin time(TT),glucose(GLU) and glycosylated hemoglobin(HbA 1C ) were determined in 31 NIDDM patients, whom were diagnosed more than five years ago and have had no complications.分别测定血浆凝血酶原时间 (PT)、活化部分凝血酶原时间 (APTT)、凝血酶时间 (TT)、纤维蛋白原 (Fg)、空腹血糖 (Glu)、糖化血红蛋白 (HbA1c)水平。
3)partial thromboplastin time活化部分凝血酶原时间
1.Methods The levels of prothrombin time(PT),partial thromboplastin time(APTT),thrombin time(TT),fibrinogen(FIB),triglyceride(TG),total cholesterol(CH) were determined in patients with type 2 diabetes mellitus(n=85) and controls(n=60).方法 分别检测糖尿病组(n=85 )和对照组(n =6 0 )血浆凝血酶原时间(PT)、活化部分凝血酶原时间(APTT)、凝血酶时间(TT)、纤维蛋白原(FIB)、甘油三酯(TG)、胆固醇(CH)。
4)Activated partial thromboplastin time活化部分凝血活酶时间
1.Influence of the Time and Temperature on the Results of Prothrombin Time,Activated Partial Thromboplastin Time,Thrombin Time and Fibrinogen;时间和温度对凝血酶原时间、活化部分凝血活酶时间、凝血酶时间、纤维蛋白原检测结果的影响分析
2.Objective To investigate the effects of different storage temperatures on anticoagulated blood hemagglutination tests,including prothrombin time(PT),and activated partial thromboplastin time(APTT).目的探讨不同的抗凝血体外贮存条件对凝血酶原时间(PT)、活化部分凝血活酶时间(APTT)的影响。
3.Objective To determine the contents of some factors and the protime (PT) and activated partial thromboplastin time (APTT) of the platelet cryoprecipitate suspension and conduct a comparison with the common blood components, so as to make a lab study to develop a new blood component.目的 检测血小板 冷沉淀悬液中某些成分含量和凝血酶原时间 (protime ,PT)、活化部分凝血活酶时间 (acti vatedpartialthromboplastintime ,APTT)对其进行初步研究 ,并与现临床常用的血液成分作一对照比较 ,为开发新型血液成份制品作一初步实验研究。
5)APTT活化部分凝血活酶时间
1.Methods 21 blood samples were selected randomly, each sample was separated into two parts, one part was stored at 4℃, another part was stored at 20℃, for 2 h、4 h、6 h、8 h respectively for PT、APTT test.目的探讨标本在4℃和20℃放置不同时间对活化部分凝血活酶时间(APTT)和凝血酶原时间(PT)结果的影响。
2.Levels of platelet count(PLT),D-dimer(DD),prothrombin time (PT),thrombin time(TT),activated partial thromboplastin time (APTT) and fibrinogen (FBG) were measured in all patients at the admission day.方法:将2005年6月至2006年12月入住我院重症监护病房的脓毒症患者分为生存组30例,死亡组16例,分别检测血小板计数(PLT)、D-二聚体(DD)、凝血酶原时间(PT)、凝血酶时间(TT)、活化部分凝血活酶时间(APTT)、纤维蛋白原(FBG),分析比较两组患者的差异及主要凝血指标与病情严重度(APACHEII评分)的关系。
3.Methods the value of prothrombin time(PT), partial thromboplastintime(APTT), tissueplasminogen activator(t PA), D dimer(D D), fibrinogen(Fbg) and fibrin degradation products(FDP) were determined in 20 normal pregnant women, 20 nomal nonpregnant women and 35 patients with PIH.方法 :检测 35例妊高征患者的凝血酶原时间 (PT)、活化部分凝血活酶时间 (APTT)、组织型纤溶酶原激活物活性 (t PA)、D 二聚体 (D D)、纤维蛋白原 (Fbg)及纤维蛋白降解产物 (FDP)的含量并与 2 0例正常孕妇及 2 0例育龄健康非孕妇比较分析。
6)Activated partial thromboplastic time部分活化凝血活酶时间
延伸阅读

凝血酶原时间测定凝血酶原时间测定prothrombin time 在血浆中加入组织凝血活酶和钙离子后,测定凝血所需要的时间,即凝血酶原时间,为反映外源性凝血系统有无障碍的一种试验。方法有试管法与玻片法。参考值为12~14s。临床意义:①其延长与肝细胞损害程度有一定关系;②在严重肝病时,如凝血酶、纤维蛋白原和血小板都降低及出现纤维蛋白降解物,则为弥漫性血管内凝血的证据;③黄疸伴该值延长,如经肌注维生素K后纠正,提示阻塞性黄疸;④用肝素或双香豆素治疗时,监测凝血酶原时间,确定抗凝药的用量及观察疗效。